HCHC / HC2 Holdings Inc - SEC Filings, Annual Report, Proxy Statement

Indenture governing the 10.500% senior secured notes due 2027, dated as of August 4, 2025, by and among INNOVATE Corp., the guarantors party thereto and U.S. Bank Trust Company, National Association

a202508048k-exhibit41 Exhibit 4.1 INNOVATE CORP. AND EACH OF THE SUBSIDIARY GUARANTORS PARTY HERETO 10.500% SENIOR SECURED NOTES DUE 2027 INDENTURE Dated as of August 4, 2025 U.S. Bank Trust Company, National Association Trustee and Collateral Trustee TABLE OF CONTENTS Page Article 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions...............................................

Indenture governing the 9.500% convertible senior secured notes due 2027, dated as of August 4, 2025, by and among INNOVATE Corp., the guarantors party thereto and U.S. Bank Trust Company, National Association

a202508048k-exhibit44 Exhibit 4.4 INNOVATE CORP. as Issuer EACH OF THE SUBSIDIARY GUARANTORS PARTY HERETO AND U.S. Bank Trust Company, National Association as Trustee and Collateral Trustee Indenture Dated as of August 4, 2025 9.5% Convertible Senior Secured Notes due 2027 (i) Table of Contents Page Article 1. DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION.................................

Amended and Restated Senior Secured Promissory Note dated as of August 4, 2025 by and between R2 Technologies, Inc. and Lancer Capital LLC (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on August 5, 2025 (File No. 001-35210)

Exhibit 10.3 AMENDED AND RESTATED SENIOR SECURED PROMISSORY NOTE $43,506,458.86 August 4, 2025 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $43,506,458.86. Interest shall accrue from the date

Amendment No. 4 of Senior Secured Promissory Note dated effective as of July 31, 2025, by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.2 AMENDMENT NO. 4 OF SENIOR SECURED PROMISSORY NOTE This Amendment No. 4 of Senior Secured Promissory Note (this “Amendment”), dated effective as of July 31, 2025 (the “Effective Date”), is entered into by and between R2 Technologies, Inc., a Delaware corporation (the “Company”), and Lancer Capital LLC (“Investor”). Capitalized terms used herein, but not otherwise defined herein, shall

INNOVATE Closes Indebtedness Refinancing Transactions INNOVATE’s Maturity Profile Has Been Successfully Extended

Exhibit 99.1 INNOVATE Closes Indebtedness Refinancing Transactions INNOVATE’s Maturity Profile Has Been Successfully Extended NEW YORK, August 4, 2025 - INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that it has closed a series of previously announced indebtedness refinancing transactions that will, among other things, exchange or amend existing instruments representing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 5, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

INNOVATE Corp. 2025 INNOVATE Corp. Q2 2025 Earnings Release Supplement August 5, 2025 INNOVATE Corp. 2025 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigatio

q22025earningswebcast-fi INNOVATE Corp. 2025 INNOVATE Corp. Q2 2025 Earnings Release Supplement August 5, 2025 INNOVATE Corp. 2025 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time m

Seventh Amendment to Credit Agreement, dated as of July 31, 2025, among INNOVATE Corp., the guarantors party thereto and MSD PCOF Partners IX, LLC

Exhibit 4.7 SEVENTH AMENDMENT TO CREDIT AGREEMENT This SEVENTH AMENDMENT TO CREDIT AGREEMENT, dated as of July 31, 2025 (this “Agreement”), among INNOVATE CORP., a Delaware corporation (the “Borrower”), DBM GLOBAL INTERMEDIATE HOLDCO INC., a Delaware corporation (“DBM Intermediate”), INNOVATE 2 CORP., a Delaware corporation (“Innovate 2” and, together with DBM Intermediate, the “Guarantors”), and

Eighth Amendment to Credit Agreement, dated as of August 4, 2025, among INNOVATE Corp., the guarantors party thereto and MSD PCOF Partners IX, LLC

a202508048k-exhibit48 Execution Version EIGHTH AMENDMENT TO CREDIT AGREEMENT This EIGHTH AMENDMENT TO CREDIT AGREEMENT, dated as of August 4, 2025 (this “Agreement”), among INNOVATE CORP.

First supplemental indenture to the indenture governing the 7.5% convertible senior notes due 2026, dated as of February 1, 2021, by and between HC2 Holdings, Inc. and U.S. Bank National Association (incorporated by reference to Exhibit 4.6 to the Current Report on Form 8-K filed on August 5, 2025) (File No. 001-35210)

Exhibit 4.6 FIRST SUPPLEMENTAL INDENTURE FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of August 4, 2025, between INNOVATE Corp. (f/k/a HC2 Holdings, Inc.), a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee under the Indenture referred to below (the “Trustee”). W I T N E S S E T H WHEREAS, the Company has heretofore execu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 31, 2025 INNOVATE CORP. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 31, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

Subordinated Secured Promissory Note dated August 4, 2025 by and between INNOVATE Corp. and Continental General Insurance Company

Exhibit 10.1 INNOVATE CORP. SUBORDINATED SECURED PROMISSORY NOTE $42,983,070.27 August 4, 2025 FOR VALUE RECEIVED, and subject to the terms and conditions set forth herein, INNOVATE CORP., a Delaware corporation (the “Borrower” or the “Company”), hereby unconditionally promises to pay to the order of CONTINENTAL GENERAL INSURANCE COMPANY or its assigns (the “Noteholder”, and together with the Borr

Side Letter to Tenth Omnibus Amendment to Secured Notes, dated as of August 4, 2025, by and among Innovate Corp., MassMutual Ascend Life Insurance Company, Great American Insurance Company and MSD PCOF Partners XVIII, LLC

Exhibit 4.10 August 4, 2025 Mass Mutual Ascend Life Insurance Company c/o Barings LLC 300 S. Tryon Street, Suite 2500 Charlotte, NC 28202 Great American Insurance Company c/o American Money Management Corporation 301 E. Fourth St., Cincinnati, OH 45202 MSD PCOF Partners XVIII, LLC 645 Fifth Avenue, 21st Floor New York, NY 10022 Re: Side Letter Agreement Re: Note Extension To Whom It May Concern: R

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in

First supplemental indenture to the indenture governing the 8.500% senior secured notes due 2026, dated as of February 1, 2021, by and among HC2 Holdings, Inc., the guarantors party thereto and U.S. Bank National Association (incorporated by reference to Exhibit 4.3 to the Current Report on Form 8-K filed on August 5, 2025) (File No. 001-35210)

Exhibit 4.3 FIRST SUPPLEMENTAL INDENTURE FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of August 4, 2025, by and among INNOVATE Corp. (f/k/a HC2 Holdings, Inc.), a Delaware corporation (the “Company”), the subsidiary guarantors party to the Indenture referred to below (the “Subsidiary Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”

INNOVATE Corp. Announces Second Quarter 2025 Results - Infrastructure: Improved financial flexibility with recent refinancing transactions - - Life Sciences: R2 continuing to see significant year over year growth in system unit sales - - Spectrum: La

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Second Quarter 2025 Results - Infrastructure: Improved financial flexibility with recent refinancing transactions - - Life Sciences: R2 continuing to see significant year over year growth in system unit sales - - Spectrum: Launched fourth ATSC 3.0 station in collaboration with large mobile carrier - NEW YORK, NY, August 5, 2025 - INNOVATE Corp. (“INNO

, 2025, by and among HC2 Station Group, Inc., HC2 Broadcasting Inc., HC2 Network Inc., DTV America Corporation, HC2 Broadcasting Intermediate Holdings Inc., HC2 Broadcasting Holdings Inc., MSD PCOF Partners XVIII, LLC, Mass Mutual Ascend Life Insurance Company and Great American Insurance Company

Exhibit 4.9 TENTH OMNIBUS AMENDMENT TO SECURED NOTES AND LIMITED CONSENT TO MSD SECURED NOTE AND INTERCREDITOR AGREEMENT This TENTH OMNIBUS AMENDMENT TO SECURED NOTES AND LIMITED CONSENT TO MSD SECURED NOTE AND INTERCREDITOR AGREEMENT (this “Amendment”), is entered into as of August 4, 2025, by and among HC2 STATION GROUP, INC., HC2 BROADCASTING INC., HC2 NETWORK INC., DTV AMERICA CORPORATION (col

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 31, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

INNOVATE Announces Early Results of Exchange Offer of Senior Secured Notes and Solicitation of Consents and Extends Availability of Total Early Exchange Consideration

Exhibit 99.1 INNOVATE Announces Early Results of Exchange Offer of Senior Secured Notes and Solicitation of Consents and Extends Availability of Total Early Exchange Consideration NEW YORK, July 31, 2025 - INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced the early participation results as of 5:00 p.m., New York City time, on July 30, 2025 (the “Early Participation Deadline

INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend

Exhibit 99.1 INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend NEW YORK, NY, July 28, 2025 (GLOBE NEWSWIRE) - INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $4.4 million,

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 28, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

INNOVATE Launches Indebtedness Refinancing Transactions $48.7 million privately negotiated convertible notes exchanges. $330 million exchange offer of senior secured notes and solicitation of consents Agreement in principle to extend revolving credit

Exhibit 99.1 INNOVATE Launches Indebtedness Refinancing Transactions $48.7 million privately negotiated convertible notes exchanges. $330 million exchange offer of senior secured notes and solicitation of consents Agreement in principle to extend revolving credit agreement Agreement in principle to amend and extend the CGIC note Agreement in principle to extend Spectrum notes Agreement in principl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 17, 2025 INNOVATE CORP. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 17, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 12, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

INNOVATE’s Portfolio Company DBM Global To Pay Cash Dividend

Exhibit 99.1 INNOVATE’s Portfolio Company DBM Global To Pay Cash Dividend NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) - INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $5.5 million, or $

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 23, 2025 INNOVATE CORP. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 23, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 20, 2025 INNOVATE CORP. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 20, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Number

DBM GLOBAL ENTERS INTO AN AMENDED AND RESTATED CREDIT AGREEMENT

Exhibit 99.1 DBM GLOBAL ENTERS INTO AN AMENDED AND RESTATED CREDIT AGREEMENT NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) - INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), has entered into an amended and restated credit agreement that provides for an $85 million term loan and a $135 million revolving credit facility (the “Credit Facility”), which

Amended and Restated Credit Agreement, dated as of May 20, 2025, by and among DBM Global Inc., the other Borrowers listed on Schedule 1.1 thereto, the Lenders, which are party thereto from time to time and UMB Bank, n.a., a national banking association, as Letter of Credit Issuer and as Administrative Agent

QB\93617747.10 Exbhibit 10.1 AMENDED AND RESTATED CREDIT AGREEMENT DATED AS OF May 20, 2025 AMONG DBM GLOBAL INC. AND THE OTHER BORROWERS, THE LENDERS, AND UMB BANK, N.A., AS ADMINISTRATIVE AGENT FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS CO-LEAD ARRANGER QB\93617747.10 TABLE OF CONTENTS Page -i- ARTICLE I DEFINITIONS ................................................................................

INNOVATE Corp. ™ 2025 INNOVATE Corp. Q1 2025 Earnings Release Supplement May 6, 2025 INNOVATE Corp. ™ 2025 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigati

INNOVATE Corp. ™ 2025 INNOVATE Corp. Q1 2025 Earnings Release Supplement May 6, 2025 INNOVATE Corp. ™ 2025 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-loo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 6, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Number)

INNOVATE Corp. Announces First Quarter 2025 Results - Infrastructure: DBM Global first quarter revenue of $264.9 million - - Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) System Received FDA Approval to Assess Kidney Function - - Spectrum: Expe

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces First Quarter 2025 Results - Infrastructure: DBM Global first quarter revenue of $264.9 million - - Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) System Received FDA Approval to Assess Kidney Function - - Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year - NEW YORK, NY, May 6, 2025 - INNOVATE Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Third Amended & Restated Limited Liability Company Agreement of Pansend Life Sciences, LLC, dated as of November 21, 2019, by and among INNOVATE Corp 2 (f/k/a HC2 Holdings 2, Inc.), David Present and Cherine Plumaker (filed herewith)

5108218-8 PANSEND LIFE SCIENCES, LLC THIRD AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT DATED AS OF November 21, 2019 Exhibit 10.

and Lancer Capital LLC (incorporated by reference to Exhibit 10.2 (

Exhibit 4.21 REGISTRATION RIGHTS AGREEMENT between HC2 HOLDINGS, INC. and LANCER CAPITAL LLC Dated as of September 9, 2020 Table of Contents 1. Certain Definitions 1 2. Shelf Registration 3 3. Piggyback Registration 5 4. Holdback Agreements 7 5. Registration Procedures 8 6. Registration Expenses 11 7. Indemnification 11 8. Transfer of Registration Rights 13 9. Prohibitions on Requests; Stockholder

Form of Restricted Stock Unit Award Agreement (filed herewith)

Exhibit 10.33 INNOVATE CORP. RESTRICTED STOCK UNIT AWARD AGREEMENT THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (the “Agreement”), is made effective as of [DATE] (hereinafter the “Date of Grant”), between INNOVATE Corp. (the “Company”), and [NAME] (the “Participant”). RECITALS: WHEREAS, the Company has adopted the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan (as amended

INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results - Infrastructure: DBM Global fourth quarter revenue of $225.7 million - - Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) system received FDA approval to assess kidney function -

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results - Infrastructure: DBM Global fourth quarter revenue of $225.7 million - - Life Sciences: MediBeacon® Transdermal GFR (“TGFR”) system received FDA approval to assess kidney function - - Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 - NEW YORK, NY, March 31,

Subsidiaries of INNOVATE (filed herewith)

Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT(1) Subsidiary Jurisdiction of Organization DBM Global Intermediate Holdco Inc. Delaware INNOVATE 2 Corp Delaware INNOVATE International Holding Corp. Delaware Subsidiaries of DBM Global Intermediate Holdco Inc., INNOVATE 2 Corp. and INNOVATE International Holding Corp., are listed below. All subsidiaries are wholly-owned by their respective parent, excep

Amendment No. 3 of Senior Secured Promissory Note dated, effective as of December 31, 2024, by and between R2 Technologies, Inc. and Lancer Capital LLC (filed herewith)

Exhibit 10.34 AMENDMENT NO. 3 OF SENIOR SECURED PROMISSORY NOTE This Amendment No. 3 of Senior Secured Promissory Note (this “Amendment”), dated effective as of December 31, 2024 (the “Effective Date”), is entered into by and between R2 Technologies, Inc., a Delaware corporation (the “Company”), and Lancer Capital LLC (“Investor”). Capitalized terms used herein, but not otherwise defined herein, s

INNOVATE Corp. ™ 2025 INNOVATE Corp. Q4 2024 Earnings Release Supplement March 31, 2025 INNOVATE Corp. ™ 2025 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litig

INNOVATE Corp. ™ 2025 INNOVATE Corp. Q4 2024 Earnings Release Supplement March 31, 2025 INNOVATE Corp. ™ 2025 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in its

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 31, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 6, 2025 INNOVATE CORP. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 6, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

MediBeacon® Transdermal GFR System receives device approval in China Peer-reviewed articles on MediBeacon technology published

MediBeacon® Transdermal GFR System receives device approval in China Peer-reviewed articles on MediBeacon technology published •Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 25, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File N

JOINT FILING AGREEMENT

EX-99.1 2 ex991to13g.htm Exhibit 99.1 EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Shares, par value $0.001 per share, of INNOVATE Corp. dated January 24, 2025 and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function •Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 17, 2025 INNOVATE CORP. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 17, 2025 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Nu

JOINT FILING AGREEMENT

EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13D/A with respect to the common stock of Innovate Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 20, 2024 INNOVATE CORP.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 20, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File N

INNOVATE Corp. Portfolio Company R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands.

Exhibit 99.1 INNOVATE Corp. Portfolio Company R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands. NEW YORK, November 20, 2024 - R2 Technologies, Inc., the world leader in CryoAesthetics® with its cutting-edge Glacial Skin systems (“R2”), a portfolio company of INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced tod

VATE / INNOVATE Corp. / Jefferies Financial Group Inc. - SC 13G/A Passive Investment

SC 13G/A 1 ef20038553sc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* INNOVATE Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 45784J303 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate b

INNOVATE Corp. Announces Third Quarter 2024 Results - Infrastructure: DBM Global third quarter revenue of $232.8 million - - Life Sciences: R2 reports record worldwide system unit sales growth in the third quarter - - Spectrum: Broadcasting's deliver

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Third Quarter 2024 Results - Infrastructure: DBM Global third quarter revenue of $232.8 million - - Life Sciences: R2 reports record worldwide system unit sales growth in the third quarter - - Spectrum: Broadcasting's delivered another quarter of strong growth driven by network launches - NEW YORK, NY, November 6, 2024 - INNOVATE Corp. (“INNOVATE” or

INNOVATE Corp. ™ 2024 INNOVATE Corp. Q3 2024 Earnings Release Supplement November 6, 2024 INNOVATE Corp. ™ 2024 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Lit

INNOVATE Corp. ™ 2024 INNOVATE Corp. Q3 2024 Earnings Release Supplement November 6, 2024 INNOVATE Corp. ™ 2024 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forwar

onvertible Participating Preferred Stock, Series A-2 Convertible Participating Preferred Stock, Series B Non-Voting Participating Convertible Preferred Stock, Series B Preferred Stock, and Series C Non-Voting Pa

Exhibit 3.2 CERTIFICATE OF ELIMINATION OF THE CERTIFICATES OF DESIGNATION OF THE SERIES A CONVERTIBLE PARTICIPATING PREFERRED STOCK, SERIES A-1 CONVERTIBLE PARTICIPATING PREFERRED STOCK, SERIES A-2 CONVERTIBLE PARTICIPATING PREFERRED STOCK, SERIES B NON-VOTING PARTICIPATING CONVERTIBLE PREFERRED STOCK, SERIES B CONVERTIBLE PARTICIPATING PREFERRED STOCK AND SERIES C NON-VOTING PARTICIPATING CONVERT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specifie

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 6, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Nu

As filed with the Securities and Exchange Commission on October 30, 2024

As filed with the Securities and Exchange Commission on October 30, 2024 Registration No.

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) INNOVATE Corp. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type  Security Class Title Fee  Calculation  Rule  Amount Registered(1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee  Fees to be Paid Equity common s

hird Amended and Restated Certificate of Incorporation of INNOVATE Corp., dated

Delaware The First State Page 1 2375835 8100 Authentication: 204527934 SR# 20243823860 Date: 10-01-24 You may verify this certificate online at corp.

(incorporated by reference to Exhibit A to INNOVATE’s Information Statement on Schedule 14C, filed with the SEC on October 7, 2024)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 (Rule 14c-101) SCHEDULE 14C INFORMATION STATEMENT October 7, 2024 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 ☒ Filed by the registrant ☐ Filed by a party other than the registrant ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement INNOVATE Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 27, 2024 INNOVATE CORP. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 27, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Num

INNOVATE Corp. Regains Compliance with NYSE Minimum Price Requirement

Exhibit 99.1 INNOVATE Corp. Regains Compliance with NYSE Minimum Price Requirement NEW YORK, September 3, 2024 (GLOBE NEWSWIRE) - INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it has received a letter from the New York Stock Exchange (“NYSE”) dated August 27, 2024 (the “Compliance Notice”), notifying the Company that it is no longer considered below the NYSE’s cont

Certificate of Amendment to Second Amended and Restated Certificate of Incorporation of INNOVATE Corp., dated

Exhibit 3.1 CERTIFICATE OF AMENDMENT TO SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INNOVATE CORP. INNOVATE Corp. (the “Corporation”), a corporation organized and existing under the Delaware General Corporation Law (the “DGCL”), by its duly authorized officer, does hereby certify that: 1.The name of the Corporation is INNOVATE Corp. 2.The amendments set forth herein have been duly

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 8, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 7, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

Collateral Trust Agreement dated as of November 20, 2018 among HC2 Holdings, Inc., the other Grantors from time to time party hereto, U.S. Bank National Association, as Trustee under the Indenture and U.S. Bank National Association, as Collateral Trustee

Exhibit 10.3 COLLATERAL TRUST AGREEMENT dated as of November 20, 2018 among HC2 HOLDINGS, INC., the other Grantors from time to time party hereto, U.S. BANK NATIONAL ASSOCIATION, as Trustee under the Indenture and U.S. BANK NATIONAL ASSOCIATION, as Collateral Trustee TABLE OF CONTENTS Page ARTICLE 1. DEFINITIONS; PRINCIPLES OF CONSTRUCTION 1 SECTION 1.1 Defined Terms 1 SECTION 1.2 Other Definition

INNOVATE Corp. ™ 2024 INNOVATE Corp. Q2 2024 Earnings Release Supplement August 7, 2024 INNOVATE Corp. ™ 2024 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litig

INNOVATE Corp. ™ 2024 INNOVATE Corp. Q2 2024 Earnings Release Supplement August 7, 2024 INNOVATE Corp. ™ 2024 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-

Third Amendment to Credit Agreement dated as of June 28, 2024, by and among DBM Global Inc., the other Borrowers listed on Schedule 1.1 hereto and UMB BANK, N.A. (filed herewith)

Exhibit 10.6 THIRD AMENDMENT TO CREDIT AGREEMENT DATED AS OF June 28, 2024 AMONG DBM GLOBAL INC. AND THE OTHER BORROWERS, THE LENDERS, AND UMB BANK, N.A., AS ADMINISTRATIVE AGENT BMO BANK N.A., AS SYNDICATION AGENT FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS DOCUMENTATION AGENT THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT is dated as of June 28, 2024 (the “Effective

INNOVATE Corp. Announces Second Quarter 2024 Results - Infrastructure: DBM Global achieved second quarter revenue of $305.2 million - - Life Sciences: R2 achieved record Glacial system sales in North America in the second quarter - - Spectrum: Broadc

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Second Quarter 2024 Results - Infrastructure: DBM Global achieved second quarter revenue of $305.2 million - - Life Sciences: R2 achieved record Glacial system sales in North America in the second quarter - - Spectrum: Broadcasting's growth driven by launch of new networks and cost-cutting efforts - NEW YORK, NY, August 7, 2024 - INNOVATE Corp. (“INNO

Amendment No. 2 of Senior Secured Promissory Note dated effective as of May 17, 2024 by and between R2 Technologies, Inc. and Lancer Capital LLC ((incorporated by reference to Exhibit 10.7 to the Quarterly Report on Form 10-Q filed on August 7, 2024) (File No. 001-35210)

Exhibit 10.7 AMENDMENT NO. 2 OF SENIOR SECURED PROMISSORY NOTE This Amendment No. 2 of Senior Secured Promissory Note (this “Amendment”), dated effective as of May 17, 2024 (the “Effective Date”), is entered into by and between R2 Technologies, Inc., a Delaware corporation (the “Company”), and Lancer Capital LLC (“Investor”). Capitalized terms used herein, but not otherwise defined herein, shall h

Amendment No. 1 to Collateral Trust Agreement, dated as of February 1, 2021, to the Collateral Trust Agreement, dated as of November 20, 2018

Exhibit 10.4 AMENDMENT NO. 1 TO COLLATERAL TRUST AGREEMENT AMENDMENT NO. 1 TO COLLATERAL TRUST AGREEMENT, dated as of February 1, 2021 (this “Amendment”), to the Collateral Trust Agreement, dated as of November 20, 2018 (as amended, supplemented, amended and restated or otherwise modified and in effect from time to time, the “Collateral Trust Agreement”), among HC2 HOLDINGS, INC. (the “Issuer”), t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in

Collateral Trust Joinder - Additional Pari Passu Obligations dated

Exhibit 10.5 COLLATERAL TRUST JOINDER – ADDITIONAL PARI PASSU OBLIGATIONS February 1, 2021 Reference is made to the Collateral Trust Agreement dated as of November 20, 2018 (as amended, supplemented, amended and restated or otherwise modified and in effect from time to time, including, without limitation, as amended by this Collateral Trust Joinder, the “Collateral Trust Agreement”) among HC2 HOLD

Joint Filing Agreement by and between Avram Glazer, Lancer Capital LLC and Avram Glazer Irrevocable Exempt Trust dated June 21, 2024.

EX-99.1 2 tm2417825d1ex1.htm EXHIBIT 1 EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13D/A with respect to the common stock of Innovate Corp. beneficially owned by each of them. This Join

HCHC / HC2 Holdings Inc / Avram Glazer Irrevocable Exempt Trust - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240.13d-1(a) and Amendments Thereto Filed Pursuant to § 240.13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 13)* Innovate Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 4041

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 18, 2024 INNOVATE CORP. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 18, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

Certificate of Amendment to Second Amended and Restated Certificate of Incorporation of INNOVATE Corp., as amended, dated June 1

Exhibit 3.1 CERTIFICATE OF AMENDMENT TO SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INNOVATE CORP. INNOVATE CORP. (the “Corporation”), a corporation organized and existing under the Delaware General Corporation Law (the “DGCL”), by its duly authorized officer, does hereby certify that: 1. The name of the Corporation is INNOVATE Corp. 2. The amendments set forth herein have been dul

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 13, 2024 INNOVATE CORP. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 13, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

INNOVATE Corp. ™ 2024 INNOVATE Corp. Q1 2024 Earnings Release Supplement May 7, 2024 INNOVATE Corp. ™ 2024 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigati

INNOVATE Corp. ™ 2024 INNOVATE Corp. Q1 2024 Earnings Release Supplement May 7, 2024 INNOVATE Corp. ™ 2024 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-loo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in

Amendment of Senior Secured Promissory Note dated effective as of April 30, 2024 by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.4 AMENDMENT OF SENIOR SECURED PROMISSORY NOTE This Amendment of Senior Secured Promissory Note (this “Amendment”), dated effective as of April 30, 2024 (the “Effective Date”), is entered into by and between R2 Technologies, Inc., a Delaware corporation (the “Company”), and Lancer Capital LLC (“Investor”). Capitalized terms used herein, but not otherwise defined herein, shall have the me

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 7, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Number)

INNOVATE Corp. Announces First Quarter 2024 Results - Infrastructure: DBM Global achieved first quarter revenue of $307.9 million - - Life Sciences: R2 delivered record North America system sales in the first quarter 2024 - - Spectrum: Broadcasting's

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces First Quarter 2024 Results - Infrastructure: DBM Global achieved first quarter revenue of $307.9 million - - Life Sciences: R2 delivered record North America system sales in the first quarter 2024 - - Spectrum: Broadcasting's revenue growth driven by launch of new networks - NEW YORK, NY, May 7, 2024 - INNOVATE Corp. (“INNOVATE” or the “Company”) (NYS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

INNOVATE Corp. Announces Closing of Rights Offering

Exhibit 99.1 INNOVATE Corp. Announces Closing of Rights Offering New York, April 24, 2024 - INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today the closing of its successful rights offering, which expired at 5:00 p.m., New York City time, on April 19, 2024. Pursuant to the terms of the rights offering, 5.2 million shares of common stock are bei

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 24, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 22, 2024 INNOVATE CORP. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 22, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

INNOVATE Corp. Announces Preliminary Results of Rights Offering

Exhibit 99.1 INNOVATE Corp. Announces Preliminary Results of Rights Offering New York, April 22, 2024 - INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today the preliminary results of its successful rights offering, which expired at 5:00 p.m., New York City time, on April 19, 2024 (the “expiration date”). According to Computershare Trust Company

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

INNOVATE Corp. Announces Further Extension of Rights Offering Subscription Period

Exhibit 99.1 INNOVATE Corp. Announces Further Extension of Rights Offering Subscription Period New York, April 9, 2024 - INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that its Board of Directors has extended the subscription period for its rights offering to 5:00 p.m. Eastern Time on April 19, 2024, in order to allow stockholders and note

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 9, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

INNOVATE Corp. Rights to Purchase up to $19.0 Million of Common Stock

Amendment No. 2 to Prospectus Supplement Dated March 8, 2024 Filed Pursuant to Rule 424(b)(5) (To the Prospectus dated October 6, 2023) Registration No. 333-274760 INNOVATE Corp. Rights to Purchase up to $19.0 Million of Common Stock This Amendment No. 2 to prospectus supplement amends the prospectus supplement dated March 8, 2024 as previously amended by Amendment No. 1 thereto dated March 25, 20

Joint Filing Agreement by and between Avram Glazer, Lancer Capital LLC and Avram Glazer Irrevocable Exempt Trust dated March 29, 2024.

EX-99.3 2 tm2410340d1ex3.htm EXHIBIT 3 EXHIBIT 3 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13D/A with respect to the common stock of Innovate Corp. beneficially owned by each of them. This Join

HCHC / HC2 Holdings Inc / Avram Glazer Irrevocable Exempt Trust - SC 13D/A Activist Investment

SC 13D/A 1 tm2410340-1sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240.13d-1(a) and Amendments Thereto Filed Pursuant to § 240.13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 12)* Innovate Corp. (Name of Issuer) Common Stock, par value $0.001 per

Certificate of Designations of Series C Non-Voting Participating Convertible Preferred Stock of INNOVATE Corp. dated March 28, 2024 (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed on March 28, 2024 (File No. 001-35210)

Exhibit 4.1 CERTIFICATE OF DESIGNATIONS OF SERIES C NON-VOTING PARTICIPATING CONVERTIBLE PREFERRED STOCK OF INNOVATE CORP. The undersigned, Paul K. Voigt, the Interim Chief Executive Officer of INNOVATE Corp. (including any successor in interest, the “Company”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify, in acc

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 28, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

INNOVATE Corp. Announces Extension of Rights Offering Subscription Period

Exhibit 99.1 INNOVATE Corp. Announces Extension of Rights Offering Subscription Period New York, March 25, 2024 - INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that its Board of Directors has extended the subscription period for its rights offering to 5:00 p.m. Eastern Time on April 9, 2024, in order to allow stockholders and noteholders

INNOVATE Corp. Rights to Purchase up to $19.0 Million of Common Stock

Amendment No. 1 to Prospectus Supplement Dated March 8, 2024 Filed Pursuant to Rule 424(b)(5) (To the Prospectus dated October 6, 2023) Registration No. 333-274760 INNOVATE Corp. Rights to Purchase up to $19.0 Million of Common Stock This Amendment No. 1 to prospectus supplement amends the prospectus supplement dated March 8, 2024 (the “original prospectus supplement”). This Amendment No. 1 to pro

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 25, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 20, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

FORM OF BENEFICIAL OWNER LETTER FOR TRANSFER OR SALE OF RIGHTS

Exhibit 99.7 FORM OF BENEFICIAL OWNER LETTER FOR TRANSFER OR SALE OF RIGHTS March  , 2024 INNOVATE Corp. 295 Madison Avenue, 12th Floor New York, New York 10017 [email protected] Attn: Michael Sena Re: Transfer or Sale of Rights Dear Mr. Sena: This letter is being submitted to INNOVATE Corp., a Delaware corporation (the “Company”), in connection with the Company’s rights offering (the “Rights

FORM OF NOMINEE HOLDER LETTER FOR TRANSFER OR SALE OF RIGHTS

Exhibit 99.8 FORM OF NOMINEE HOLDER LETTER FOR TRANSFER OR SALE OF RIGHTS March  , 2024 INNOVATE Corp. 295 Madison Avenue, 12th Floor New York, New York 10017 [email protected] Attn: Michael Sena Re: Transfer or Sale of Rights Dear Mr. Sena: This letter is being submitted to INNOVATE Corp., a Delaware corporation (the “Company”), in connection with the Company’s rights offering (the “Rights O

INNOVATE Corp. Announces Commencement of Rights Offering

Exhibit 99.9 FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Commencement of Rights Offering New York, March 8, 2024 - INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that it has commenced its previously announced $19.0 million rights offering for its common stock. All INNOVATE stockholders will have the opportunity to participate in the off

INNOVATE CORP. FORM OF BROKER LETTER TO CLIENTS WHO ARE BENEFICIAL HOLDERS Subscription Rights to Purchase Shares of Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of INNOVATE Corp.

Exhibit 99.4 INNOVATE CORP. FORM OF BROKER LETTER TO CLIENTS WHO ARE BENEFICIAL HOLDERS Subscription Rights to Purchase Shares of Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of INNOVATE Corp. March 8, 2024 To Our Clients: Enclosed for your consideration are a Base Prospectus, dated October 6, 2023 (the “Base Prospectus”), and a Prospectus Supplement, dated Marc

FORM OF INSTRUCTIONS AS TO USE OF INNOVATE CORP. RIGHTS CERTIFICATE PLEASE CONSULT OKAPI PARTNERS LLC, THE INFORMATION AGENT, YOUR BANK OR BROKER AS TO ANY QUESTIONS.

Exhibit 99.1 FORM OF INSTRUCTIONS AS TO USE OF INNOVATE CORP. RIGHTS CERTIFICATE PLEASE CONSULT OKAPI PARTNERS LLC, THE INFORMATION AGENT, YOUR BANK OR BROKER AS TO ANY QUESTIONS. The following instructions relate to a rights offering (the “Rights Offering”) by INNOVATE Corp., a Delaware corporation (the “Company”), (i) to all holders of record (“Record Holders”) of shares of its Common Stock, par

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 8, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

INNOVATE CORP. FORM OF NOMINEE HOLDER CERTIFICATION

Exhibit 99.6 INNOVATE CORP. FORM OF NOMINEE HOLDER CERTIFICATION The undersigned, a broker, dealer, bank, or other nominee holder of transferable subscription rights (“Rights”) to purchase shares of common stock, par value $0.001 per share (“Common Stock”), of INNOVATE Corp., a Delaware corporation (the “Company”), pursuant to the rights offering described and provided for in the Company’s Base Pr

Form of Subscription Rights Certificate

Exhibit 4.1 . + Computershare Trust Company, N.A. 150 Royall Street Canton Massachusetts 02021 For questions call the Information Agent Okapi Partners LLC at (855) 208-8902 MRA SAMPLE DESIGNATION(IF ANY) ADD ADD 2 ADD 3 ADD 4 ADD 5 NNNNNNNNN ADD 6 C NNNNNN 1234567890J N T Primary Subscription 12345678901234 Rights SUBSCRIPTION RIGHTS CERTIFICATE INNOVATE CORP. SUBSCRIPTION RIGHTS FOR SHARES OF COM

INNOVATE CORP. FORM OF BENEFICIAL HOLDER ELECTION FORM

Exhibit 99.5 INNOVATE CORP. FORM OF BENEFICIAL HOLDER ELECTION FORM The undersigned acknowledge(s) receipt of your letter and the enclosed materials referred to therein relating to the offering of shares of common stock, par value $0.001 per share (“Common Stock”), of INNOVATE Corp., a Delaware corporation (the “Company”). Capitalized terms used herein and not otherwise defined herein shall have t

INNOVATE CORP. FORM OF LETTER TO BROKERS, DEALERS, BANKS, AND OTHER NOMINEES Subscription Rights to Purchase Shares of Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of INNOVATE Corp.

Exhibit 99.3 INNOVATE CORP. FORM OF LETTER TO BROKERS, DEALERS, BANKS, AND OTHER NOMINEES Subscription Rights to Purchase Shares of Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of INNOVATE Corp. March 8, 2024 To Brokers, Dealers, Banks, and Other Nominees: This letter is being distributed to brokers, dealers, banks, and other nominees in connection with the righ

INNOVATE Corp. Rights to Purchase up to $19.0 Million of Common Stock

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-274760 Prospectus Supplement (To the Prospectus dated October 6, 2023) INNOVATE Corp. Rights to Purchase up to $19.0 Million of Common Stock We are distributing (i) to the holders (collectively, the “stockholders”) of our common stock, par value $0.001 per share (the “common stock”), our Series A-3 Convertible Participating Pr

INNOVATE CORP. FORM OF LETTER TO STOCKHOLDERS WHO ARE RECORD HOLDERS Subscription Rights to Purchase Shares of Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of INNOVATE Corp.

Exhibit 99.2 INNOVATE CORP. FORM OF LETTER TO STOCKHOLDERS WHO ARE RECORD HOLDERS Subscription Rights to Purchase Shares of Common Stock Offered Pursuant to Subscription Rights Distributed to Stockholders of INNOVATE Corp. March 8, 2024 Dear Stockholder: This notice is being distributed by INNOVATE Corp., a Delaware corporation (the “Company”), (i) to all holders of record (“Record Holders”) of sh

INNOVATE Corp. Insider Trading Policy effective November 2, 2023 (filed herewith).

Exhibit 10.67 Updated: November 2, 2023 INNOVATE CORP. INSIDER TRADING POLICY INNOVATE CORP. INSIDER TRADING POLICY Purpose The purpose of this Insider Trading Policy (the Policy”) is to promote compliance with applicable securities laws by INNOVATE Corp. (“INNOVATE” or the “Company”) and its subsidiaries and all directors, officers and employees thereof, in order to preserve the reputation and in

Amended and Restated Senior Secured Promissory Note dated January 31, 2024 by and between R2 Technologies, Inc. and Lancer Capital LLC (

Exhibit 10.72 SENIOR SECURED PROMISSORY NOTE $20,000,000.00 January 31, 2024 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $20,000,000.00. Interest shall accrue from the date of this Secured P

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 6, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

INNOVATE Corp. Clawback Policy effective November 2, 2023 (filed herewith).

Exhibit 10.66 INNOVATE CORP. CLAWBACK POLICY The Board of Directors (the “Board”) of INNOVATE Corp. (the “Company”) believes that it is appropriate for the Company to adopt this Clawback Policy (the “Policy”) to be applied to the Executive Officers of the Company and adopts this Policy to be effective as of the Effective Date. 1. Definitions For purposes of this Policy, terms defined in the preamb

(incorporated by reference to Exhibit 10.70 to the Annual Report on Form 10-K filed on March 6, 2024 (File No. 001-35210)

Exhibit 10.70 INVESTMENT AGREEMENT between INNOVATE Corp. as the Company and LANCER CAPITAL LLC as the Purchaser Dated as of March 5, 2024 TABLE OF CONTENTS Page 1. Authorization of Preferred Shares 1 2. Sale and Purchase of Back-stop and Private Placement 1 3. Back-stop/Private Placement Closing; Payment of Purchase Price 2 3.1. Back-stop/Private Placement Closing Date. 2 3.2. Issuance of Preferr

INNOVATE Corp. Announces Rights Offering Pricing

Exhibit 99.1 INNOVATE Corp. Announces Rights Offering Pricing New York, March 6, 2024 - INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that it has approved the pricing for its previously announced rights offering. The Company will distribute to each holder of the Company’s common stock as of March 6, 2024 (the “rights offering record date”

Second Amendment to Credit Agreement, dated as of December 12, 2023, among DBM Global Inc. and the other Borrowers, the Lenders, UMB Bank, n.a., as Administrative Agent and BMO Harris Bank N.A., as Syndication Agent (filed herewith).

Exhibit 10.68 SECOND AMENDMENT TO CREDIT AGREEMENT DATED AS OF December 12, 2023 AMONG DBM GLOBAL INC. AND THE OTHER BORROWERS, THE LENDERS, AND UMB BANK, N.A., AS ADMINISTRATIVE AGENT BMO HARRIS BANK N.A., AS SYNDICATION AGENT QB\85666270.4 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT is dated as of December , 2023 (the “Effective Date”), by and among DBM GLOBAL

Subsidiaries of INNOVATE (filed herewith).

Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT(1) Subsidiary Jurisdiction of Organization DBM Global Intermediate Holdco Inc. Delaware INNOVATE 2 Corp Delaware INNOVATE International Holding Corp. Delaware TIC Holdco Inc.(2) Delaware Subsidiaries of DBM Global Intermediate Holdco Inc., INNOVATE 2 Corp. and INNOVATE International Holding Corp., are listed below. All subsidiaries are wholly-owned by th

ublease Agreement dated as of December 19, 2023, by and between INNOVATE Corp. and Palm Beach Cultural Innovation Center Inc. (filed herewith).

Exhibit 10.69 SUBLEASE AGREEMENT THIS SUBLEASE AGREEMENT (the "Sublease") is made as of the 19th day of December, 2023 (the “Execution Date”) by and between INNOVATE CORP. (the "Sublessor") having an office at 222 Lakeview Avenue, Suite 1660, West Palm Beach, Florida 33401 and PALM BEACH CULTURAL INNOVATION CENTER INC. (the "Sublessee") a Florida not-for-profit corporation having an office at 70 R

Amendment of Senior Secured Promissory Notes dated as of November 15, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.65 AMENDMENT OF SENIOR SECURED PROMISSORY NOTES This Amendment of Senior Secured Promissory Notes (this “Amendment”), dated effective as of November 15, 2023 (the “Effective Date”), is entered into by and between R2 Technologies, Inc., a Delaware corporation (the “Company”), and Lancer Capital LLC (“Investor”). Capitalized terms used herein, but not otherwise defined herein, shall have

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in its

between INNOVATE Corp. and Lancer Capital LLC

Exhibit 10.71 REGISTRATION RIGHTS AGREEMENT between INNOVATE Corp. and LANCER CAPITAL LLC Dated as of March 5, 2024 Table of Contents 1 Certain Definitions 1 2 Shelf Registration. 3 3 Piggyback Registration. 5 4 Holdback Agreements. 7 5 Registration Procedures. 8 6 Registration Expenses. 11 7 Indemnification. 11 8 Transfer of Registration Rights 13 9 Prohibitions on Requests; Stockholders’ Obligat

INNOVATE Corp. Announces Fourth Quarter and Full Year 2023 Results - Infrastructure: DBM Global achieved fourth quarter revenue of $353.8 million - - Life Sciences: R2 experienced strong North America unit sales in the fourth quarter - - Spectrum: Br

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Fourth Quarter and Full Year 2023 Results - Infrastructure: DBM Global achieved fourth quarter revenue of $353.8 million - - Life Sciences: R2 experienced strong North America unit sales in the fourth quarter - - Spectrum: Broadcasting entered into agreements with PBS stations for new commercial opportunities with ATSC 3.0 - NEW YORK, NY, March 4, 202

INNOVATE Corp. ™ 2024 INNOVATE Corp. Q4 2023 Earnings Release Supplement March 4, 2024 INNOVATE Corp. ™ 2024 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litiga

INNOVATE Corp. ™ 2024 INNOVATE Corp. Q4 2023 Earnings Release Supplement March 4, 2024 INNOVATE Corp. ™ 2024 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-l

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 4, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 26, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File N

INNOVATE Corp. Announces Rights Offering for Common Stock

Exhibit 99.1 FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Rights Offering for Common Stock New York, February 26, 2024 - INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that its Board of Directors (the “Board”) has approved a plan to proceed with and fixed a record date for an $19.0 million rights offering for its common stock. All INNOVA

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 26, 2024 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File N

INNOVATE Corp. Announces Third Quarter 2023 Results - Infrastructure: DBM Global achieved third quarter revenue of $369.3 million and once again delivered gross margin expansion versus prior year - - Life Sciences: MediBeacon continues to work throug

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Third Quarter 2023 Results - Infrastructure: DBM Global achieved third quarter revenue of $369.3 million and once again delivered gross margin expansion versus prior year - - Life Sciences: MediBeacon continues to work through regulatory approval with the FDA - - Spectrum: Broadcasting explores strategic partnerships for additional growth opportunitie

enior Secured Promissory Note dated as of August 15, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC (filed herewith)

Exhibit 10.6 SENIOR SECURED PROMISSORY NOTE $562,500.00 August 15, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $562,500.00. Interest shall accrue from the date of this Secured Promissor

Amended and Restated Financial Support Commitment Letter from Lancer Capital LLC dated November 7, 2023

Exhibit 10.10 Lancer Capital, LLC 222 Lakeview Avenue, Suite 1660 West Palm Beach, FL 33401 November 7, 2023 INNOVATE Corp. 222 Lakeview Ave., Suite 1660 West Palm Beach FL 33401 Re: Financial Support Commitment To Whom It May Concern: This letter sets forth the terms and conditions upon which Lancer Capital LLC, a Delaware limited liability company ("Lancer") agrees to provide financial support t

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 9, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Nu

Ninth Omnibus Amendment to Secured Notes, dated as of November 9, 2023, by and among, HC2 Station Group, Inc., HC2 Broadcasting Inc., HC2 Network Inc., DTV America Corporation, HC2 Broadcasting Intermediate Holdings Inc., HC2 Broadcasting Holdings Inc., MSD PCOF Partners XVIII, LLC, MassMutual Ascend Life Insurance Company and Great American Insurance Company (incorporated by reference to Exhibit 10.11 to the Quarterly Report on Form 10-Q filed by INNOVATE on November 9, 2023) (File No. 001-35210)

Exhibit 10.11 NINTH OMNIBUS AMENDMENT TO SECURED NOTES AND LIMITED CONSENT TO MSD SECURED NOTE AND INTERCREDITOR AGREEMENT This NINTH OMNIBUS AMENDMENT TO SECURED NOTES AND LIMITED CONSENT TO MSD SECURED NOTE AND INTERCREDITOR AGREEMENT (this “Amendment”), is entered into as of November 9, 2023, by and among HC2 STATION GROUP, INC., HC2 BROADCASTING INC., HC2 NETWORK INC., DTV AMERICA CORPORATION

Amendment of Senior Secured Promissory Notes dated as of August 15, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC (incorporated by reference to Exhibit 10.7 to the Quarterly Report on Form 10-Q filed by INNOVATE on November 9, 2023) (File No. 001-35210).

Exhibit 10.7 AMENDMENT OF SENIOR SECURED PROMISSORY NOTES This Amendment of Senior Secured Promissory Notes (this “Amendment”), dated effective as of August 15, 2023 (the “Effective Date”), is entered into by and between R2 Technologies, Inc., a Delaware corporation (the “Company”), and Lancer Capital LLC (“Investor”). Capitalized terms used herein, but not otherwise defined herein, shall have the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specifie

INNOVATE Corp. ™ 2023 INNOVATE Corp. Q3 2023 Earnings Release Supplement November 9, 2023 INNOVATE Corp. ™ 2023 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Lit

INNOVATE Corp. ™ 2023 INNOVATE Corp. Q3 2023 Earnings Release Supplement November 9, 2023 INNOVATE Corp. ™ 2023 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forwar

Side Letter to Ninth Omnibus Amendment to Secured Notes, dated as of November 9, 2023, by and among,HC2 Station Group, Inc., HC2 Broadcasting Inc., HC2 Network, Inc., DTV America Corporation, HC2 Broadcasting Intermediate Holdings, Inc., HC2 Broadcasting Holdings, Inc., and MassMutual Life Insurance Company and Great American Insurance Company (incorporated by reference to Exhibit 10.12 to the Quarterly Report on Form 10-Q filed by INNOVATE on November 9, 2023) (File No. 001-35210)

Exhibit 10.12 November 9, 2023 Mass Mutual Ascend Life Insurance Company c/o Barings LLC 300 S. Tryon Street, Suite 2500 Charlotte, NC 28202 Great American Insurance Company c/o American Money Management Corporation 301 E. Fourth St., Cincinnati, OH 45202 Re: Side Letter Agreement Re: Note Extension To Whom It May Concern: Reference is made to that certain Amended and Restated Secured Note dated a

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 6, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Num

Employment Agreement dated as of October 6, 2023 by and between Paul K. Voigt and INNOVATE Corp.

Exhibit 10.1 October 6, 2023 Paul Voigt 62 Allwood Road Darien, Connecticut 06820 Re: Terms of Employment as Interim Chief Executive Officer Dear Mr. Voigt, This letter sets forth the terms and conditions of employment of Paul Voigt ("Executive") by INNOVATE Corp., a Delaware corporation (the "Company") as its Interim Chief Executive Officer. 1.Duties. As Interim Chief Executive Officer, Executive

October 3, 2023

October 3, 2023 VIA EDGAR Bradley Ecker Division of Corporation Finance Office of Manufacturing Securities and Exchange Commission 100 F Street, N.

Filing Fee Table

Exhibit 107.1 Calculation of Filing Fee Table Form S-3 (Form Type) INNOVATE, Corp. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Share (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered

As filed with the Securities and Exchange Commission on September 29, 2023

As filed with the Securities and Exchange Commission on September 29, 2023 Registration No.

(incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by INNOVATE on September 21, 2023)

Exhibit 10.1 SEPARATION AND RELEASE AGREEMENT This Separation and Release Agreement (the “Agreement”) is entered into effective as of September 21, 2023 between INNOVATE Corp. (the “Employer” or the “Company”) and Suzi Herbst (“Employee”) (the Employer and Employee will be collectively referred to hereinafter as the “Parties”). WHEREAS, Employee and the Company are parties to that certain Employme

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 21, 2023 INNOVATE CORP.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 21, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File

28, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC (filed

Exhibit 10.7 SENIOR SECURED PROMISSORY NOTE $472,500.00 June 28, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $472,500.00. Interest shall accrue from the date of this Secured Promissory

Amendment of Senior Secured Promissory Notes dated as of July 28, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.9 AMENDMENT OF SENIOR SECURED PROMISSORY NOTES This Amendment of Senior Secured Promissory Notes (this “Amendment”), dated as of July 28, 2023 (the “Effective Date”), is entered into by and between R2 Technologies, Inc., a Delaware corporation (the “Company”), and Lancer Capital LLC (“Investor”). Capitalized terms used herein, but not otherwise defined herein, shall have the meaning ass

Senior Secured Promissory Note dated as of May 12, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.3 SENIOR SECURED PROMISSORY NOTE $525,000.00 May 12, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $525,000.00. Interest shall accrue from the date of this Secured Promissory N

Senior Secured Promissory Note dated as of May 31, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.4 SENIOR SECURED PROMISSORY NOTE $650,000.00 May 31, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $650,000.00. Interest shall accrue from the date of this Secured Promissory N

Eighth Omnibus Amendment to Secured Notes, dated as of August 8, 2023, by and among, HC2 Station Group, Inc., HC2 Broadcasting Inc., HC2 Network Inc., DTV America Corporation, HC2 Broadcasting Intermediate Holdings Inc., HC2 Broadcasting Holdings Inc., MSD PCOF Partners XVIII, LLC, MassMutual Ascend Life Insurance Company and Great American Insurance Company

Exhibit 10.11 EIGHTH OMNIBUS AMENDMENT TO SECURED NOTES This EIGHTH OMNIBUS AMENDMENT TO SECURED NOTES (this “Amendment”), is entered into as of August 8, 2023, by and among HC2 STATION GROUP, INC., HC2 BROADCASTING INC., HC2 NETWORK INC., DTV AMERICA CORPORATION (collectively, the “Subsidiary Borrowers”), HC2 BROADCASTING INTERMEDIATE HOLDINGS INC. (the “Intermediate Parent”), HC2 BROADCASTING HO

Senior Secured Promissory Note and amendment dated as of July 14, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.8 SENIOR SECURED PROMISSORY NOTE $562,500.00 July 14, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $562,500.00. Interest shall accrue from the date of this Secured Promissory

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in

Senior Secured Promissory Note dated as of July 28, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.10 SENIOR SECURED PROMISSORY NOTE $562,500.00 July 28, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $562,500.00. Interest shall accrue from the date of this Secured Promissory

Financial Support Commitment from Lancer Capital LLC dated August 11, 2023

Exhibit 10.12 Lancer Capital, LLC 222 Lakeview Avenue, Suite 1660 West Palm Beach, FL 33401 August 8, 2023 INNOVATE Corp. 222 Lakeview Ave., Suite 1660 West Palm Beach FL 33401 Re: Financial Support Commitment To Whom It May Concern: This letter sets forth the terms and conditions upon which Lancer Capital LLC, a Delaware limited liability company ("Lancer") agrees to provide financial support to

INNOVATE Corp. Announces Second Quarter 2023 Results - Infrastructure: DBM Global achieved second quarter revenue of $362.4 million and delivered gross margin expansion versus prior year - - Life Sciences: MediBeacon filed Clinical Study Report with

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Second Quarter 2023 Results - Infrastructure: DBM Global achieved second quarter revenue of $362.4 million and delivered gross margin expansion versus prior year - - Life Sciences: MediBeacon filed Clinical Study Report with FDA - - Spectrum: Broadcasting sees indications of stabilization in linear TV networks; new OTA distribution opportunities emerg

INNOVATE Corp. ™ 2023 INNOVATE Corp. Q2 2023 Earnings Release Supplement August 9, 2023 INNOVATE Corp. ™ 2023 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litig

vateq22023earningswebcas INNOVATE Corp. ™ 2023 INNOVATE Corp. Q2 2023 Earnings Release Supplement August 9, 2023 INNOVATE Corp. ™ 2023 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to ti

2023 by and between R2 Technologies, Inc. and Lancer Capital LLC (filed

Exhibit 10.6 AMENDMENT OF SENIOR SECURED PROMISSORY NOTES This Amendment of Senior Secured Promissory Notes (this “Amendment”), dated as of June 28, 2023 (the “Effective Date”), is entered into by and between R2 Technologies, Inc., a Delaware corporation (the “Company”), and Lancer Capital LLC (“Investor”). Capitalized terms used herein, but not otherwise defined herein, shall have the meaning ass

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 9, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

Senior Secured Promissory Note dated as of June 14, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.5 SENIOR SECURED PROMISSORY NOTE $562,500.00 June 14, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $562,500.00. Interest shall accrue from the date of this Secured Promissory

INNOVATE Corp. Names Paul K. Voigt Interim CEO

Exhibit 99.1 INNOVATE Corp. Names Paul K. Voigt Interim CEO NEW YORK, July 25, 2023 – INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that the Board has named Paul K. Voigt Interim Chief Executive Officer, effective immediately. Suzi Herbst, who had been serving as interim CEO immediately following the passing of Wayne Barr, will remain the Company’s Chief Operating Offic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 25, 2023 INNOVATE CORP. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 25, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 23, 2023 INNOVATE CORP. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 23, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

INNOVATE Corp. Announces the Untimely Passing of CEO Wayne Barr

Exhibit 99.1 INNOVATE Corp. Announces the Untimely Passing of CEO Wayne Barr NEW YORK, July 23, 2023 – INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that Wayne Barr, President, Chief Executive Officer and Director, passed away unexpectedly on July 22, 2023. The Board has appointed Chief Operating Officer Suzi Herbst as Interim Chief Executive Officer. Avram Glazer, Chai

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 15, 2023 INNOVATE CORP. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 15, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

Subordinated Unsecured Promissory Note dated as of May 9, 2023 by and between INNOVATE Corp. and Continental General Insurance Company

Exhibit 10.6 INNOVATE CORP. SUBORDINATED UNSECURED PROMISSORY NOTE $35,123,476.34 May 9, 2023 FOR VALUE RECEIVED, and subject to the terms and conditions set forth herein, INNOVATE CORP., a Delaware corporation (the "Borrower" or the "Company"), hereby unconditionally promises to pay to the order of CONTINENTAL GENERAL INSURANCE COMPANY or its assigns (the "Noteholder," and together with the Borro

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in

Stock Purchase Agreement dated as of May 9, 2023 by and between INNOVATE Corp. and Continental General Insurance Company

Exhibit 10.5 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this "Agreement"), dated as of May 9, 2023 (the "Effective Date"), is entered into by and between INNOVATE CORP., a Delaware corporation (the "Company") and CONTINENTAL GENERAL INSURANCE COMPANY, a Texas domiciled life and health insurance company ("Seller"). Company and Seller may be referred to herein individually as a "Party"

© INNO VATE Corp. 2023 INNOVATE Corp. Q1 2023 Earnings Release Supplement May 10, 2023 © INNO VATE Corp. 2023 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litig

vateq12023earningswebcas © INNO VATE Corp. 2023 INNOVATE Corp. Q1 2023 Earnings Release Supplement May 10, 2023 © INNO VATE Corp. 2023 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to ti

INNOVATE Corp. Announces First Quarter 2023 Results - Infrastructure: DBM Global delivered first quarter revenue of $311.7 million - - Life Sciences:R2 Technologies receives expanded FDA clearances - - Spectrum: Broadcasting's station revenues increa

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces First Quarter 2023 Results - Infrastructure: DBM Global delivered first quarter revenue of $311.7 million - - Life Sciences:R2 Technologies receives expanded FDA clearances - - Spectrum: Broadcasting's station revenues increased in the first quarter - NEW YORK, May 10, 2023 - INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today it

by and between R2 Technologies, Inc. and Lancer Capital LLC (filed herewith).

Exhibit 10.1 SENIOR SECURED PROMISSORY NOTE $520,000.00 February 15, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $520,000.00. Interest shall accrue from the date of this Secured Promiss

Senior Secured Promissory Note dated as of March 31, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC (

Exhibit 10.3 SENIOR SECURED PROMISSORY NOTE $13,039,393.37 March 31, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $13,039,393.37. Interest shall accrue from the date of this Secured Prom

Senior Secured Promissory Note dated as of February 28, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.2 SENIOR SECURED PROMISSORY NOTE $424,414.00 February 28, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $424,414.00. Interest shall accrue from the date of this Secured Promiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 10, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Number

Senior Secured Promissory Note dated as of April 28, 2023 by and between R2 Technologies, Inc. and Lancer Capital LLC

Exhibit 10.4 SENIOR SECURED PROMISSORY NOTE $425,000.00 April 28, 2023 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $425,000.00. Interest shall accrue from the date of this Secured Promissory

INNOVATE Corp. Announces Date Change for First Quarter 2023 Earnings Call

Exhibit 99.1 INNOVATE Corp. Announces Date Change for First Quarter 2023 Earnings Call May 2, 2023 NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) - INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”), today announced a change to its first quarter 2023 earnings results and conference call date. The Company will now report its first quarter 2023 financial results after market close on Wednesday, May

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 2, 2023 INNOVATE CORP. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 2, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 25, 2023 INNOVATE CORP. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 25, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 30, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

INNOVATE Corp. Adopts Tax Benefit Preservation Plan

Exhibit 99.1 INNOVATE Corp. Adopts Tax Benefit Preservation Plan NEW YORK, April 3, 2023 – INNOVATE Corp. (“INNOVATE” or “the Company”) (NYSE: VATE), today announced that its Board of Directors voted to adopt a Tax Benefits Preservation Plan (the “2023 Plan”) designed to protect the availability of INNOVATE’s net operating loss carryforwards ("NOLs") and other tax attributes under the Internal Rev

, by and between INNOVATE Corp. and Computershare Trust Company, N.A.

INNOVATE CORP. and COMPUTERSHARE TRUST COMPANY, N.A., as Rights Agent, TAX BENEFITS PRESERVATION PLAN Dated as of April 1, 2023 TABLE OF CONTENTS Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 7 Section 3. Issuance of Rights Certificates 7 Section 4. Form of Rights Certificates 9 Section 5. Countersignature and Registration 10 Section 6. Transfer, Split-Up, Combinatio

Tax Benefits Preservation Plan, dated as of April 1, 2023, by and between INNOVATE Corp. and Computershare Trust Company, N.A.

EX-4.1 2 a202304038-a12bxexh41.htm EX-4.1 INNOVATE CORP. and COMPUTERSHARE TRUST COMPANY, N.A., as Rights Agent, TAX BENEFITS PRESERVATION PLAN Dated as of April 1, 2023 TABLE OF CONTENTS Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 7 Section 3. Issuance of Rights Certificates 7 Section 4. Form of Rights Certificates 9 Section 5. Countersignature and Registration 10

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 INNOVATE CORP. (Exact name of registrant as spe

8-A12B 1 a202304038-a12b.htm 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 54-1708481 (State or other jurisdiction of incorporation) (I.R.S. Employer Identif

© INNOVATE Corp. 2023 INNOVATE Corp. Q4 2022 Earnings Release Supplement March 14, 2023 © INNOVATE Corp. 2023 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litig

© INNOVATE Corp. 2023 INNOVATE Corp. Q4 2022 Earnings Release Supplement March 14, 2023 © INNOVATE Corp. 2023 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release contains, and certain oral statements made by our representatives from time to time may contain, "forward

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in its

INNOVATE Corp. Announces Fourth Quarter and Full Year 2022 Results - Infrastructure: DBM Global finishes year strong; achieves 37% revenue growth for 2022 - - Life Sciences: MediBeacon completed enrollment of both U.S. and China Pivotal Studies - - S

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Fourth Quarter and Full Year 2022 Results - Infrastructure: DBM Global finishes year strong; achieves 37% revenue growth for 2022 - - Life Sciences: MediBeacon completed enrollment of both U.S. and China Pivotal Studies - - Spectrum: Broadcasting added contracts with three major networks and launched new programming - - Company meets Continued Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 14, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

Subsidiaries of INNOVATE (filed herewith).

Exhibit 21.1 SUBSIDIARIES OF THE REGISTRANT Subsidiary Jurisdiction of Organization DBM Global Intermediate Holdco Inc. Delaware INNOVATE 2 Corp Delaware INNOVATE International Holding Corp. Delaware TIC Holdco Inc. (f/k/a Schuff Merger Sub, Inc.) Delaware Subsidiaries of DBM Global Intermediate Holdco Inc., INNOVATE 2 Corp. and INNOVATE International Holding Corp., are listed below. All subsidiar

Senior Secured Promissory Note dated as of December 13, 2022 by and between R2 Technologies, Inc. and Lancer Capital LLC (

Exhibit 10.44 SENIOR SECURED PROMISSORY NOTE $811,000.00 December 13, 2022 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the “Company”), promises to pay to Lancer Capital LLC (the “Holder”), or its permitted assigns, in lawful money of the United States of America the principal sum of $811,000.00. Interest shall accrue from the date of this Secured Promis

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 6, 2023 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

INNOVATE Corp. Completes Sale of Remaining Equity Stake in HMN International

Exhibit 99.1 INNOVATE Corp. Completes Sale of Remaining Equity Stake in HMN International NEW YORK, March 7, 2023 – INNOVATE Corp. (NYSE: VATE), today announced that it has closed the sale of the remaining 19% interest in HMN International Co. Ltd., formerly known as Huawei Marine Networks Co. (“HMN”), to subsidiaries and an affiliate of Hengtong Optic-Electric Co Ltd. The 19% HMN stake was held b

Mutual Release and Termination Agreement dated as of December 31, 2022, by and among Azteca International Corporation and TV Azteca, S.A.B. de C.V., HC2 Network, Inc. and TV Azteca, S.A.B. de C.V. (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed by INNOVATE on January 5, 2023) (File No. 001-35210

EX-10.3 4 a202212308-kxexh103.htm EX-10.3 Exhibit 10.3 MUTUAL RELEASE AND TERMINATION AGREEMENT This MUTUAL RELEASE AND TERMINATION AGREEMENT (this “Agreement”) is entered into as of the 31st day of December, 2022, by and among Azteca International Corporation, a Delaware corporation (“AIC”), HC2 Network Inc., a Delaware corporation, (“HC2 Network”) and TV Azteca, S.A.B. de C.V., a Sociedad Anónim

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 30, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File N

Letter Agreement with Continental General Insurance Company

EX-10.1 2 a202212308-kxexh101.htm EX-10.1 DocuSign Envelope ID: 795278EF-FFA4-4177-90A8-7AD735951592 Exhibit 10.1 December 30, 2022 Innovate Corp. 295 Madison Avenue, 12th Floor New York, New York 10017 RE: Agreement to Vote Excess Shares Ladies and Gentlemen: As of the date hereof, Continental General Insurance Company, a Texas domiciled life and health insurance company (“CGIC”), together with c

Seventh Omnibus Amendment to Secured Notes

Exhibit 10.2 SEVENTH OMNIBUS AMENDMENT TO SECURED NOTES This SEVENTH OMNIBUS AMENDMENT TO SECURED NOTES (this ?Amendment?), is entered into as of December 30, 2022, by and among HC2 STATION GROUP, INC., HC2 BROADCASTING INC., HC2 NETWORK INC., HC2 BROADCASTING LICENSE INC., DTV AMERICA CORPORATION (collectively, the ?Subsidiary Borrowers?), HC2 BROADCASTING INTERMEDIATE HOLDINGS INC. (the ?Interme

[Signature page follows]

EX-99.1 2 ex991to13da1013108001010423.htm LETTER AGREEMENT Exhibit 99.1 December 30, 2022 Innovate Corp. 295 Madison Avenue, 12th Floor New York, New York 10017 RE:Agreement to Vote Excess Shares Ladies and Gentlemen: As of the date hereof, Continental General Insurance Company, a Texas domiciled life and health insurance company (“CGIC”), together with certain of its affiliates (collectively, the

HCHC / HC2 Holdings Inc / Percy Rockdale LLC - AMENDMENT NO. 10 TO THE SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 10)1 Innovate Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 404139107 (CUSIP Number) MICHAEL GORZYNSKI 595

and Great American Insurance Company (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by INNOVATE

EX-10.1 2 a202211298-kxexh101.htm EX-10.1 Exhibit 10.1 EXECUTION VERSION SIXTH OMNIBUS AMENDMENT TO SECURED NOTES This SIXTH OMNIBUS AMENDMENT TO SECURED NOTES (this “Amendment”), is entered into as of November [], 2022, by and among HC2 STATION GROUP, INC., HC2 LPTV HOLDINGS, INC., HC2 BROADCASTING INC., HC2 NETWORK INC., HC2 BROADCASTING LICENSE INC., DTV AMERICA CORPORATION (collectively, the “

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 28, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File N

MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System MediBeacon approaching completion of Phase 3 study focused on kidney disease; Has submitted three of five requ

EX-99.1 2 a202211168-kxexh991.htm EX-99.1 Exhibit 99.1 CONTACT: Steve Hanley MediBeacon Inc. Office - 314-735-0971 [email protected] www.medibeacon.com MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System MediBeacon approaching completion of Phase 3 study focused on kidney disease; Has submitted three of fiv

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 16, 2022 INNOVATE CORP.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 16, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specifie

Regulation FD Disclosure, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 27, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Nu

First Amendment to Credit Agreement dated as of August 2, 2022, among DBM Global Inc. and the Other Borrowers, the Lenders, UMB Bank, as Administrative Agent and BMO Harris Bank N.A., as Syndication Agent (filed herewith).

FIRST AMENDMENT TO CREDIT AGREEMENT DATED AS OF August 2, 2022 AMONG DBM GLOBAL INC.

enior Secured Promissory Note dated as of August 8, 2022 by and between R2 Technologies, Inc. and Lancer Capital LLC (incorporated by reference to Exhibit 10.4 to the

SENIOR SECURED PROMISSORY NOTE $5,000,000.00 August 8, 2022 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the ?Company?), promises to pay to Lancer Capital LLC (the ?Holder?), or its permitted assigns, in lawful money of the United States of America the principal sum of $5,000,000.00. Interest shall accrue from the date of this Secured Promissory Note (th

© INNOVATE Corp. 2022 INNOVATE Corp. Q3 2022 Earnings Release Supplement November 2, 2022 © INNOVATE Corp. 2022 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Lit

? INNOVATE Corp. 2022 INNOVATE Corp. Q3 2022 Earnings Release Supplement November 2, 2022 ? INNOVATE Corp. 2022 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forwar

Senior Secured Promissory Note, dated as of July 13, 2022 by and between R2 Technologies, Inc. and Lancer Capital LLC (filed herewith)

SENIOR SECURED PROMISSORY NOTE $5,000,000.00 July 13, 2022 San Ramon, California For value received, R2 Technologies, Inc., a Delaware corporation (the ?Company?), promises to pay to Lancer Capital LLC (the ?Holder?), or its permitted assigns, in lawful money of the United States of America the principal sum of $5,000,000.00. Interest shall accrue from the date of this Secured Promissory Note (thi

INNOVATE Corp. Announces Third Quarter 2022 Results - Infrastructure: DBM Global delivers record revenue of $412.7 million in the third quarter driven by strong demand and grows total backlog to $1.9 billion - - Life Sciences: MediBeacon's U.S. Pivot

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Third Quarter 2022 Results - Infrastructure: DBM Global delivers record revenue of $412.7 million in the third quarter driven by strong demand and grows total backlog to $1.9 billion - - Life Sciences: MediBeacon's U.S. Pivotal Study is progressing well - - Spectrum: Broadcasting completed the upgrade to ATSC 3.0 of two of our Ft. Wayne, Indiana stati

VATE LISTED NYSE INFRASTRUCTURE • DBM Global: Largest steel fabrication and erection company in the USA LIFE SCIENCES • R2 Technologies: the first and only device to employ Cryomodulationtm using PRECISION COOLING to address SOURCES of redness, benig

VATE LISTED NYSE INFRASTRUCTURE ? DBM Global: Largest steel fabrication and erection company in the USA LIFE SCIENCES ? R2 Technologies: the first and only device to employ Cryomodulationtm using PRECISION COOLING to address SOURCES of redness, benign lesions, inflammation and more ? MediBeacon: Developing the first real-time monitoring of kidney function, which has received ?breakthrough device designation? from the FDA and is being developed to address a $7 billion(1) market SPECTRUM ? HC2 Broadcasting: One of the largest broadcast station groups in the US, owning 2.

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 22, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File

Separation and Release Agreement by and between INNOVATE Corp. and Joseph A. Ferraro dated September 13, 2022

Exhibit 99.1 SEPARATION AND RELEASE AGREEMENT This Separation and Release Agreement (the ?Agreement?) is entered into between INNOVATE Corp. (the ?Employer? or the ?Company?) and Joseph Ferraro (?Employee?) (the Employer and Employee will be collectively referred to hereinafter as the ?Parties?). WHEREAS, Employee and the Company are parties to that certain Employment Agreement dated as of Septemb

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 13, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File

INNOVATE Corp. Announces Appointment of Amy Wilkinson to the Board of Directors

INNOVATE Corp. Announces Appointment of Amy Wilkinson to the Board of Directors NEW YORK, August 2, 2022 – INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), today announced the appointment of Amy Wilkinson to fill the remaining vacancy on the INNOVATE Board of Directors. “Amy brings a unique blend of management expertise and global business and policy experience, and we are confident she

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 2, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

© INNOVATE Corp. 2022 INNOVATE Corp. Q2 2022 Earnings Release Supplement August 3, 2022 © INNOVATE Corp. 2022 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litig

? INNOVATE Corp. 2022 INNOVATE Corp. Q2 2022 Earnings Release Supplement August 3, 2022 ? INNOVATE Corp. 2022 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-

INNOVATE Corp. Announces Second Quarter 2022 Results - Infrastructure: DBM Global delivers revenue of $382.1 million in the second quarter driven by continued strength at Banker Steel and robust demand in the construction market - - Life Sciences: Me

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Second Quarter 2022 Results - Infrastructure: DBM Global delivers revenue of $382.1 million in the second quarter driven by continued strength at Banker Steel and robust demand in the construction market - - Life Sciences: MediBeacon's IDE application accepted by the FDA; begins its U.S. Pivotal Study - - Spectrum: Broadcasting maintains focus on addi

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 2, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Nu

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 3, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

INNOVATE Corp. Announces Appointment of Amy Wilkinson to the Board of Directors

INNOVATE Corp. Announces Appointment of Amy Wilkinson to the Board of Directors NEW YORK, August 2, 2022 – INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), today announced the appointment of Amy Wilkinson to fill the remaining vacancy on the INNOVATE Board of Directors. “Amy brings a unique blend of management expertise and global business and policy experience, and we are confident she

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 2, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numb

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 24, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

INNOVATE Corp. Announces Appointment of Brian Goldstein to the Board of Directors

INNOVATE Corp. Announces Appointment of Brian Goldstein to the Board of Directors NEW YORK, June 29, 2022 ? INNOVATE Corp. (?INNOVATE? or the ?Company?) (NYSE: VATE), today announced the appointment of Brian Goldstein to fill a vacancy on the INNOVATE Board of Directors, effective immediately. ?The addition of Brian strengthens INNOVATE?s Board, bringing tax expertise and a unique perspective that

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 16, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

HCHC / HC2 Holdings Inc / Percy Rockdale LLC Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 9)1 Innovate Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 404139107 (CUSIP Number) MICHAEL GORZYNSKI 595

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 12, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Numbe

INNOVATE Corp. Announces Directors Michael Gorzynski, Shelly Lombard and Kenneth Courtis Will Not Stand for Re-election

INNOVATE Corp. Announces Directors Michael Gorzynski, Shelly Lombard and Kenneth Courtis Will Not Stand for Re-election NEW YORK, June 13, 2022 ? INNOVATE Corp. (?INNOVATE? or the ?Company?) (NYSE: VATE), today announced that directors Michael Gorzynski, Shelly C. Lombard and Kenneth S. Courtis have informed the Company that they will not stand for re-election to the Board of Directors at INNOVATE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

HCHC / HC2 Holdings Inc / Avram Glazer Irrevocable Exempt Trust - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to § 240.13d-1(a) and Amendments Thereto Filed Pursuant to § 240.13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 11)* Innovate Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 4041

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

HCHC / HC2 Holdings Inc / Avram Glazer Irrevocable Exempt Trust - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to ? 240.13d-1(a) and Amendments Thereto Filed Pursuant to ? 240.13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. 10)* Innovate Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 4041

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 001-35210 INNOVATE CORP. (Exact name of registrant as specified in

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 4, 2022 INNOVATE CORP. (Exact name of registrant as specified in its charter) Delaware 001-35210 54-1708481 (State or other jurisdiction of incorporation) (Commission File Number)

INNOVATE Corp. Announces First Quarter 2022 Results - Infrastructure: DBM Global delivers record revenue of $402.2 million in the first quarter driven by Banker Steel, large-scale projects and continued momentum - - Life Sciences: R2 has now shipped

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces First Quarter 2022 Results - Infrastructure: DBM Global delivers record revenue of $402.2 million in the first quarter driven by Banker Steel, large-scale projects and continued momentum - - Life Sciences: R2 has now shipped 100 GLACIAL? devices to customers globally - - Spectrum: Broadcasting completed the construction of 22 new broadcast stations an

© INNOVATE Corp. 2022 INNOVATE Corp. Q1 2022 Earnings Release Supplement May 4, 2022 © INNOVATE Corp. 2022 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigati

? INNOVATE Corp. 2022 INNOVATE Corp. Q1 2022 Earnings Release Supplement May 4, 2022 ? INNOVATE Corp. 2022 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain, "forward-loo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (incorporated by reference to Exhibit 4.1

Exhibit 4.17 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a description of securities of INNOVATE Corp. (the ?Company?) that are registered under Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?). The summary presented below is not complete and is subject to, and is qualified in

Form of Stock Option Agreement (filed herewith).

EX-10.37 7 exhibit1037-q410xk2021.htm EX-10.37 Exhibit 10.37 INNOVATE CORP. NONQUALIFIED OPTION AWARD AGREEMENT THIS NONQUALIFIED OPTION AWARD AGREEMENT (the “Agreement”), is made as of [insert date] (the “Date of Grant”), between INNOVATE Corp. (the “Company”), and [insert name] (the “Participant”). R E C I T A L S: WHEREAS, the Company has adopted the HC2 Holdings, Inc. Second Amended and Restat